SPY330.29-4.21 -1.26%
DIA276.64-2.26 -0.81%
IXIC10,714.19-196.09 -1.80%

Oyster Point Pharma Q1 EPS $(0.77) Beats $(1.06) Estimate, No Revenue

Oyster Point Pharma (NASDAQ:OYST) reported quarterly losses of $(0.770) per share which beat the analyst consensus estimate of $(1.060) by 27.36 percent.

Benzinga · 05/11/2020 10:24

Oyster Point Pharma (NASDAQ:OYST) reported quarterly losses of $(0.770) per share which beat the analyst consensus estimate of $(1.060) by 27.36 percent.